Latest Episodes
From 200 Snake Bites to a Biotech Breakthrough in Antivenom...Dr. Jake Glanville, Founder, CEO, Chair of Centivax
This week on BioTech Nation, a call to a man who survived hundreds of venomous snake bites helps inspire the development of an antivenom vaccine. Biotech Entrepreneur,...
Hospital at Home? Dr. Daniel Kraft, Tech Nation Health Chief Correspondent
On this week's BioTech Nation, Tech Nation Health Chief Correspondent Dr. Daniel Kraft tells us about the trend of "hospital-at-home". As we see the expansion of remot...
Personalized Vaccines for Treating Glioblastoma? Jay Hartenbach & Dr. Will Decker, Diakonos Oncology
In time for the 2026 ASCO Annual Meeting in Chicago, we're highlighting 3 BioTech companies shaping the future of cancer treatment...On this episode of BioTech Nation,...
Two Drug Approvals in Two Years...Michael Metzger, CEO, Syndax Pharmaceuticals
In time for the 2026 ASCO Annual Meeting in Chicago, we're highlighting 3 BioTech companies shaping the future of cancer treatment...On this episode of BioTech Nation:...
Fighting Hard-to-Treat Cancers...Dan Schmitt, President & CEO, Actuate Therapeutics
In time for the 2026 ASCO Annual Meeting in Chicago, we're highlighting 3 BioTech companies shaping the future of cancer treatment:On this episode of BioTech Nation, D...
